This is characterized by enhanced expression of pro-inflammatory cytokines such as IFN-γ, which can also stimulate the secretion of chemokines (e.g. CXCL9, CXCL10, and CXCL11) to amplify the anti-tumour immune response (Wu et al., 2024). The gene discussed is CXCL9; the disease is neoplasm.